Pharmacokinetics of an anti-TFPI monoclonal antibody (concizumab) blocking the TFPI interaction with the active site of FXa in Cynomolgus monkeys after iv and sc administration.

MLA

Agersø, Henrik, et al. “Pharmacokinetics of an Anti-TFPI Monoclonal Antibody (Concizumab) Blocking the TFPI Interaction with the Active Site of FXa in Cynomolgus Monkeys after Iv and Sc Administration.” European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences, vol. 56, June 2014, pp. 65–69. EBSCOhost, https://doi.org/10.1016/j.ejps.2014.02.009.

APA

Agersø, H., Overgaard, R. V., Petersen, M. B., Hansen, L., Hermit, M. B., Sørensen, M. H., Petersen, L. C., & Hilden, I. (2014). Pharmacokinetics of an anti-TFPI monoclonal antibody (concizumab) blocking the TFPI interaction with the active site of FXa in Cynomolgus monkeys after iv and sc administration. European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences, 56, 65–69. https://doi.org/10.1016/j.ejps.2014.02.009

Chicago

Agersø, Henrik, Rune Viig Overgaard, Mads Bjelke Petersen, Lene Hansen, Mette Brunsgaard Hermit, Mette Høgh Sørensen, Lars Christian Petersen, and Ida Hilden. 2014. “Pharmacokinetics of an Anti-TFPI Monoclonal Antibody (Concizumab) Blocking the TFPI Interaction with the Active Site of FXa in Cynomolgus Monkeys after Iv and Sc Administration.” European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences 56 (June): 65–69. doi:10.1016/j.ejps.2014.02.009.